Drug Watch

Latest News

psychedelic
Positive Results From the Phase 2b Study of BPL-003 in Patients With Treatment-Resistant Depression

July 1st 2025

New clinical trial results reveal BPL-003's rapid and durable antidepressant effects, paving the way for innovative treatments in treatment-resistant depression.

child ADHD
FDA Requires New Label Warning of Weight Loss Risk in Pediatric Patients Taking Extended-Release Stimulants for ADHD

July 1st 2025

pharma
June in Review: Updates on the Psychiatric Treatment Pipeline

June 30th 2025

depression
ALTO-203 Fails to Primary Efficacy Endpoint in Phase 2 Major Depressive Disorder Trial

June 27th 2025

psilocybin
COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data

June 23rd 2025

More News

© 2025 MJH Life Sciences

All rights reserved.